Europe Disposable Endoscopes Market Size, Share & Trends Analysis Report By Type (Gastrointestinal Endoscopes, Laproscopes), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Europe Disposable Endoscopes Market Growth & Trends
The Europe disposable endoscopes market size is estimated treach USD 1.21 billion by 2030, registering a CAGR of 7.73% from 2025 t2030, according ta new report by Grand View Research, Inc. The increasing cases of cross-contamination complications due tthe use of reusable endoscopes are driving the adoption of single-use endoscopic devices. In addition, the growing number of chronic and respiratory diseases in Europe and the shortage of medical staff for cleaning and disinfecting reusable endoscopes in between the surgical procedures drive the market for disposable endoscopes. For instance, a study published in the European Respiratory journal in 2021 stated that about 36.6 million Europeans are having COPD and the number will be increased t49.5 million by 2050. Furthermore, the risk associated with reusable endoscopes such as clogging, leakage, and the chance of contamination due tthe tedious sterilization process is further expected tboost the market growth during the forecast period.
Reusable endoscopes are the potential source of disease transmission. While the disposable bronchoscope could decrease the risk of cross-contamination, increase safety and efficiency, and can be used with limited resources. In addition, increasing recommendations by most respiratory societies tuse disposable bronchoscopes during the SARS-CoV-2 pandemic is accelerating the growth of the segment. Moreover, the ENT endoscopy segment is expected twitness the fastest growth during the forecast period owing tthe high preference for the use of disposable endoscopic devices tlimit the chances of infection during the ear, nose, and throat diagnostic procedures.
The hospitals end-use segment is expected tregister a significant growth over the forecast period. This is attributed tthe increasing patient preference for hospitals tdiagnose and treat their chronic diseases. In addition, favorable reimbursement policies and low-cost surgical procedures provided by the government hospitals are expected tboost the segment growth. Moreover, the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities are supporting the growth of the segment. The clinics segment is anticipated texpand at the fastest CAGR during the forecast period owing tthe increasing adoption of single-use endoscopes in clinics for better patient engagement with low cross-contamination chances, quick recovery time, and lower post-procedural complications.
Furthermore, the rapid rise of COVID-19 cases in Europe has limited the number of surgical procedures. However, due tthe benefits of disposable endoscopes such as lower chances of cross-contamination, time efficiency, safety, short hospital stay, and lower post-procedure infections, many endoscopic procedure facilities have increasingly adopted the single-use endoscopic devices during the COVID-19 pandemic, which favored the growth of the market in 2020. The shortage of clinical personnel due tthe viral infections and government-imposed lockdown and shutdowns further decreased the use of conventional endoscopes and in turn, increased the adoption of disposable endoscopic devices, thereby propelling the market growth during the COVID-19 pandemic.
Europe Disposable Endoscopes Market Report Highlights
Europe Disposable Endoscopes Market Growth & Trends
The Europe disposable endoscopes market size is estimated treach USD 1.21 billion by 2030, registering a CAGR of 7.73% from 2025 t2030, according ta new report by Grand View Research, Inc. The increasing cases of cross-contamination complications due tthe use of reusable endoscopes are driving the adoption of single-use endoscopic devices. In addition, the growing number of chronic and respiratory diseases in Europe and the shortage of medical staff for cleaning and disinfecting reusable endoscopes in between the surgical procedures drive the market for disposable endoscopes. For instance, a study published in the European Respiratory journal in 2021 stated that about 36.6 million Europeans are having COPD and the number will be increased t49.5 million by 2050. Furthermore, the risk associated with reusable endoscopes such as clogging, leakage, and the chance of contamination due tthe tedious sterilization process is further expected tboost the market growth during the forecast period.
Reusable endoscopes are the potential source of disease transmission. While the disposable bronchoscope could decrease the risk of cross-contamination, increase safety and efficiency, and can be used with limited resources. In addition, increasing recommendations by most respiratory societies tuse disposable bronchoscopes during the SARS-CoV-2 pandemic is accelerating the growth of the segment. Moreover, the ENT endoscopy segment is expected twitness the fastest growth during the forecast period owing tthe high preference for the use of disposable endoscopic devices tlimit the chances of infection during the ear, nose, and throat diagnostic procedures.
The hospitals end-use segment is expected tregister a significant growth over the forecast period. This is attributed tthe increasing patient preference for hospitals tdiagnose and treat their chronic diseases. In addition, favorable reimbursement policies and low-cost surgical procedures provided by the government hospitals are expected tboost the segment growth. Moreover, the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities are supporting the growth of the segment. The clinics segment is anticipated texpand at the fastest CAGR during the forecast period owing tthe increasing adoption of single-use endoscopes in clinics for better patient engagement with low cross-contamination chances, quick recovery time, and lower post-procedural complications.
Furthermore, the rapid rise of COVID-19 cases in Europe has limited the number of surgical procedures. However, due tthe benefits of disposable endoscopes such as lower chances of cross-contamination, time efficiency, safety, short hospital stay, and lower post-procedure infections, many endoscopic procedure facilities have increasingly adopted the single-use endoscopic devices during the COVID-19 pandemic, which favored the growth of the market in 2020. The shortage of clinical personnel due tthe viral infections and government-imposed lockdown and shutdowns further decreased the use of conventional endoscopes and in turn, increased the adoption of disposable endoscopic devices, thereby propelling the market growth during the COVID-19 pandemic.
Europe Disposable Endoscopes Market Report Highlights
- The market growth in Europe can be attributed tthe growing number of chronic and respiratory diseases, the shortage of medical staff, and the increasing adoption of single-use endoscopic devices in healthcare institutions in the region
- The Laparoscopes segment is anticipated twitness the fastest CAGR over the forecast period, due tgrowing prevalence of chronic diseases and conditions that require surgical intervention, such as obesity, appendicitis, gallbladder diseases, pelvic inflammatory disease, and cancers
- Based on end-use, the hospitals segment is anticipated treister significant growth, owing tthe increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE DISPOSABLE ENDOSCOPES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Industry challenges
3.3. Europe Disposable Endoscopes: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Reimbursement Framework
CHAPTER 4. EUROPE DISPOSABLE ENDOSCOPES MARKET SEGMENT ANALYSIS, BY TYPE, 2018-2030 (USD MILLION)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Europe Disposable Endoscopes Market, by Type, 2018 to 2030
4.5. Laparoscopes
4.5.1. Laparoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Arthroscopes
4.6.1. Arthroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Ureteroscopes
4.7.1. Ureteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Cystoscopes
4.8.1. Cystoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Gynecology Endoscopes
4.9.1. Gynecology Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Neuroendoscopes Disposable Endoscopes
4.10.1. Neuroendoscopes estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Hysteroscopes
4.11.1. Hysteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Laryngoscopes
4.12.1. Laryngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Otoscopes
4.13.1. Otoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Nasopharyngoscopes
4.14.1. Nasopharyngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Rhinoscopes
4.15.1. Rhinoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Gastrointestinal Europe Disposable Endoscopes
4.16.1. Gastrointestinal Europe Disposable Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.2. Gastroscope (Upper GI Endoscope)
4.16.2.1. Gastroscope (Upper GI Endoscope) market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.3. Enteroscope
4.16.3.1. Enteroscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.4. Duodenoscope
4.16.4.1. Duodenoscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.5. Colonoscope
4.16.5.1. Colonoscope market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE DISPOSABLE ENDOSCOPES MARKET SEGMENT ANALYSIS, BY END USE, 2018-2030 (USD MILLION)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Europe Disposable Endoscopes Market, by End Use, 2018 to 2030
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Outpatient facilities
5.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. REGION, BY PRODUCT, BY END USE, 2018 - 2030 (USD MILLION)
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Europe Disposable Endoscopes Market Share by Region, 2024 & 2030:
6.5. Europe
6.5.1. Europe endoscopy devices market, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. UK endoscopy devices market, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Germany endoscopy devices market, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. France endoscopy devices market, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Italy endoscopy devices market, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Spain endoscopy devices market, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Norway endoscopy devices market, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Sweden endoscopy devices market, 2018 - 2030 (USD Million)
6.5.9. Denmark
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Denmark endoscopy devices market, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Olympus Corporation
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Boston Scientific Corporation
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. PENTAX Medical (Hoya Corporation)
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. FUJIFILM Holdings Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Karl Storz GmbH & Co., KG
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Stryker
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Ambu A/S.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. STERIS plc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE DISPOSABLE ENDOSCOPES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Industry challenges
3.3. Europe Disposable Endoscopes: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Reimbursement Framework
CHAPTER 4. EUROPE DISPOSABLE ENDOSCOPES MARKET SEGMENT ANALYSIS, BY TYPE, 2018-2030 (USD MILLION)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Europe Disposable Endoscopes Market, by Type, 2018 to 2030
4.5. Laparoscopes
4.5.1. Laparoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Arthroscopes
4.6.1. Arthroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Ureteroscopes
4.7.1. Ureteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Cystoscopes
4.8.1. Cystoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Gynecology Endoscopes
4.9.1. Gynecology Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Neuroendoscopes Disposable Endoscopes
4.10.1. Neuroendoscopes estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Hysteroscopes
4.11.1. Hysteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Laryngoscopes
4.12.1. Laryngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Otoscopes
4.13.1. Otoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Nasopharyngoscopes
4.14.1. Nasopharyngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Rhinoscopes
4.15.1. Rhinoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Gastrointestinal Europe Disposable Endoscopes
4.16.1. Gastrointestinal Europe Disposable Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.2. Gastroscope (Upper GI Endoscope)
4.16.2.1. Gastroscope (Upper GI Endoscope) market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.3. Enteroscope
4.16.3.1. Enteroscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.4. Duodenoscope
4.16.4.1. Duodenoscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.5. Colonoscope
4.16.5.1. Colonoscope market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE DISPOSABLE ENDOSCOPES MARKET SEGMENT ANALYSIS, BY END USE, 2018-2030 (USD MILLION)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Europe Disposable Endoscopes Market, by End Use, 2018 to 2030
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Outpatient facilities
5.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. REGION, BY PRODUCT, BY END USE, 2018 - 2030 (USD MILLION)
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Europe Disposable Endoscopes Market Share by Region, 2024 & 2030:
6.5. Europe
6.5.1. Europe endoscopy devices market, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. UK endoscopy devices market, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Germany endoscopy devices market, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. France endoscopy devices market, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Italy endoscopy devices market, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Spain endoscopy devices market, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Norway endoscopy devices market, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Sweden endoscopy devices market, 2018 - 2030 (USD Million)
6.5.9. Denmark
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Denmark endoscopy devices market, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Olympus Corporation
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Boston Scientific Corporation
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. PENTAX Medical (Hoya Corporation)
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. FUJIFILM Holdings Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Karl Storz GmbH & Co., KG
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Stryker
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Ambu A/S.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. STERIS plc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
